The next chapter for group B meningococcal vaccines
The majority of invasive meningococcal disease (IMD) in the developed world is caused by capsular group B Neisseria meningitidis, however success with vaccination against organisms bearing this capsule has previously been restricted to control of geographically limited clonal outbreaks. As we enter...
主要な著者: | Wang, N, Pollard, A |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Taylor and Francis
2017
|
類似資料
-
Group B meningococcal vaccine science and policy
著者:: Drysdale, SB, 等
出版事項: (2015) -
Group B meningococcal vaccine: Recommendations for UK use
著者:: Pollard, A, 等
出版事項: (2014) -
Group B meningococcal vaccine: recommendations for UK use.
著者:: Pollard, A, 等
出版事項: (2014) -
Four component meningococcal capsular Group B vaccine in preterm infants.
著者:: Sadarangani, M, 等
出版事項: (2017) -
Meningococcal vaccines.
著者:: Rüggeberg, J, 等
出版事項: (2004)